Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Hydration and clinically assisted nutrition

Palliative and end-of-life care · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Acute complication of assisted intake

Aspiration with respiratory compromise, pulmonary oedema, line sepsis, tube displacement into the airway, severe electrolyte shift or refeeding syndrome can be life threatening. Assisted treatment must not continue automatically while harm is assessed.

Action: Use ABCDE assessment, stop the feed or fluid causing suspected harm, check glucose and relevant electrolytes, verify tube position and obtain urgent respiratory, nutrition, renal or critical-care help within the agreed ceiling. Treat aspiration, sepsis, overload and electrolyte deficits under the appropriate pathway and reassess whether the intervention still meets its goal.

Synopsis

Separate mouth care and supported oral intake from medical hydration and nutrition, identify reversible swallowing or metabolic problems, set a measurable goal for any assisted treatment and make lawful shared decisions to start, continue, withhold or stop it.

  • Offer safe sips, preferred tastes, eating assistance and frequent mouth care whenever wanted; reduced intake in dying is not corrected reliably by pressure to eat or automatic fluid.
  • Clinically assisted hydration includes intravenous, subcutaneous and enteral fluid; clinically assisted nutrition includes tube and parenteral feeding. Both are medical treatments requiring indication, consent and review.
  • First-line assessment identifies thirst, delirium, dysphagia, aspiration, nausea, obstruction, fluid losses, medicine effects, prognosis and the outcome the person wants treatment to achieve.
  • Use swallow assessment before unsafe oral intake. A functioning accessible gut generally favours enteral feeding; parenteral nutrition is reserved for selected patients whose gut cannot be used and who have time to benefit.
  • In the last days, evidence is uncertain that clinically assisted hydration prolongs life or extends dying; it may relieve dehydration-related symptoms or worsen oedema, ascites, secretions and repeated procedures.
  • Offer an individual therapeutic trial when benefit is plausible: state the route, volume, target symptom or function, review time and stop criteria before treatment begins.
  • Artificial nutrition cannot reverse inflammatory cachexia by itself. Explain this to reduce blame and food-related conflict while continuing enjoyable intake if safe.
  • Screen for refeeding risk before nutrition after prolonged little or no intake; give thiamine, introduce energy cautiously and monitor phosphate, potassium, magnesium, glucose and fluid.
  • A capacitous adult may refuse assisted hydration or nutrition. When capacity is absent, check any valid advance decision or attorney authority and use a documented best-interests process under the applicable UK law.
  • The gold-standard plan is goal based and reversible: continue only while the person experiences the agreed benefit without disproportionate aspiration, infection, overload, restraint or monitoring burden.

Key red flags

Cough, desaturation, wet voice or respiratory distress during feeding suggests aspiration and requires immediate cessation and assessment.

A displaced nasogastric tube must never be used until position is confirmed by the approved safety method.

Rapid breathlessness, crackles, oedema or rising oxygen need during hydration suggests fluid overload.

Fever, rigors, hypotension or inflamed central access during parenteral nutrition raises line sepsis.

Low phosphate, potassium or magnesium, arrhythmia, oedema or weakness after feeding starts suggests refeeding syndrome.

Physical restraint solely to maintain a feeding tube can create disproportionate harm and requires urgent best-interests review.

Serious family-team disagreement about starting or stopping life-sustaining nutrition needs senior mediation, second opinion and sometimes legal advice.

Refeeding syndrome

New oedema, tachycardia, weakness, confusion, arrhythmia or respiratory failure after restarting nutrition may reflect dangerous phosphate and electrolyte shifts.

Investigation priorities

01
First-line goal and intake assessmentFirst stepFirst line

Clarify desired outcome, appetite, actual intake, assistance, symptoms, cultural meaning, prognosis and burdens acceptable to the person.

Management branches

Supported oral careMaximise safe enjoyment and comfort

The person wants oral intake and can swallow some food, fluid or tastes with acceptable risk.

  1. Treat mouth pain, candidiasis, nausea and constipation, provide upright assistance and offer small preferred textures and fluids without pressure.
  2. Discuss aspiration and enjoyment openly, including a documented risk-feeding plan when the person chooses oral intake despite known risk.
  3. Review comfort, coughing, fatigue, family anxiety and intake and adapt the plan as alertness and swallowing change.

Key medicines

Thiamine for high refeeding riskGive oral thiamine 200 to 300 mg daily immediately before and during the first 10 days of feeding, with the multivitamin and electrolyte plan specified by NICE CG32; use parenteral replacement when oral absorption is unreliable.Thiamine does not replace controlled energy introduction or phosphate, potassium, magnesium, glucose and fluid monitoring; treat established deficiency or Wernicke risk under the relevant protocol.
Electrolyte replacement during refeedingReplace potassium, phosphate and magnesium using the NICE CG32 risk ranges and the local intravenous or oral protocol, adjusted to measured values, renal function, ECG and fluid status.Renal failure increases accumulation risk and intravenous phosphate or potassium can be dangerous; use frequent biochemical review and monitored administration when severe.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NICE NG31 care of dying adultsMouth care, safe drinks, hydration uncertainty, therapeutic trials and daily review.
  • NICE CG32 nutrition supportOral, enteral and parenteral selection, refeeding risk, thiamine and biochemical monitoring.
  • NICE NG108 decision making and mental capacityCapacity support, advance decisions, best interests, consultation and dispute resolution in England and Wales.
  • GMC clinically assisted nutrition guidanceProfessional duties when starting, continuing, withholding or stopping assisted nutrition and hydration.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom